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In  the  study  of  virus-induced  neoplasms  the  fluorescent-antibody  method 
provides  a  singular  opportunity  for investigating,  within  the  limits of optical 
resolution,  the  cellular  sites  of  origin  and  development  of  the  virus  (or 
specifically its  associated  antigens)  and  the  tumor.  The  purpose  of  this  com- 
munication is to present some of the qualitative and quantitative observations 
that  we  have  made  with  this  procedure  in  the  study  of  Rous  sarcoma  virus. 
Methods and Materials 
Rous Sarcoma Virus.--The  starting material for virus preparation was the harvest of wing 
tumors comprising the seventh passage in chickens of Rous sarcoma virus obtained originally 
from Dr.  W.  R. Bryan.  His procedure of selecting the most rapidly  developing tumors as 
virus-source material was used (1).  The solid tumors were pooled and homogenized at a  1:5 
dilution in isotonic saline containing 2 per cent rabbit serum, penicillin (100 units/ml.), and 
streptomycin (100/zg./ml.). The homogenate was shell-frozen and rapidly thawed three times 
and centrifuged at 2000  R.I'.M. at room temperature for 20 minutes.  The supernatant  fluid 
constituted the standard  preparation  of Rous sarcoma virus which, after suitable dilution, 
was used in this work, Table I. When assayed by the chicken wing-web technique, the tumor- 
producing  titer of the standard  preparation  was  10  ~.3 TDs0  per gin.  of original tumor,  as 
calculated  by  the  Reed-Muench  formula.  On  the  chorioallantoic membrane  of  the  chick 
embryo the assay was 10  e.5 pock-forming units per gin.  of tumor. 
Chickens and Chick Embryos.--White  Leghorn  chickens,  3  to  5  days  of age,  and  chick 
embryos,  12  days  of  age,  were  obtained  from  Shamrock  Farms,  North  Brunswick,  New 
Jersey. 
In the inoculation of wing web, the needle was passed  through muscle so as to limit the 
loss of the inoculum by back flow along the needle track. For initiating the growth of wing 
tumors with attributes tabulated in Table I and Text-figs. 1 and 2, the standard  preparation 
of Rous virus was diluted, as noted, and inoculated in 1 ml. quantity.  Groups of 20 chicks 
were employed for each virus dilution, and 6 wing tumors of most rapid growth, or if in lesser 
number  the entire yield, were chosen  from each group  for study.  The wing tumors  were 
harvested as soon as they attained an estimated diameter of about 10 ram. 
Virus Assay.--Appro~mately  one-half of each wing tumor, stored at --70°C., was homoge- 
nized, three times frozen and  thawed,  and  centrifuged to yield a  supernatant  fluid  (tumor 
extract) which was assayed by the chicken wing-web technique for tumor-producing activity, 
expressed as log10 TDs0 per gin. of tumor. Five chickens were employed for the assay of each 
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decimal dilution of tumor extract. The inoculum was 0.2  ml. The data in Table I  were the 
arithmetic means for virus extracted from tumors in each category. 
The standard preparation of Rous virus was assayed for tumor-producing activity in the 
chicken wing web and the chorioallantoic membrane. The inoculum in either prodecure was 
0.2 ml. Five chickens and 20 chick embryos were employed for each decimal dilution of virus. 
The chorioallantoic membranes were dropped conventionally and inoculated with a 20 gauge 
needle.  Embryos were incubated at  100°F. for 6 days, and the membranes were harvested, 
placed on  a  glass plate,  and with magnification and oblique illumination against a  black 
background were examined for pocks. The average pock count was determined at two or more 
~ilutions at which there was no confluence of tumor growth. 
TABLE I 
Assays of Virus and Attributes of Wing Tumors Produced b,, Rous Sarcoma Virus 
Wmnor- 
No. of  initiating 
chickens  dose of 
V~ruS* 
6  10  -2 
6  10-  4 
6  10- 6 
4  10-  7 
2  10- 8 
Latent 
period 





Age of tumor 
from  from 
virus  earliest 
inoculation  appearance 
days  days 
9  3 
9  3 
15  6 
16  7 









Virus  Sarcoma cells 
extracted  with RousIv/ral 
from tumor[[  antigens¶ 
log TDso/&m.  per cent 
8.2  12 
6.9  10 
6.0  5 
2.9  0.05 
2.8  0 
* Dilutions of a standard, cell-free  (three times frozen and thawed) preparation of Rous 
sarcoma virus. 
~; Time elapsed from inoculation of virus to earliest macroscopic evidence of tumor. 
§ Pathologist's measurement, a diameter of a cube of tumor. 
]1 TD~0, the dose of virus which produces wing tumor in 50 per cent of chickens. 
¶ Demonstrable with fluorescent antibody in frozen sections of the tumors. 
Antiserum.--Chickens 8 weeks of age were inoculated in the wing web with a stock prepa- 
ration of Rous virus that had been allowed to lose its infectivity by being maintained at 
4°C. for 4 weeks (11). No formalin or other antiviral substance was added. A chicken received 
three semimonthly injections, each comprising 1 ml. of a  10  -~ dilution. Two weeks after the 
third injection each chicken was inoculated with 0.2 ml.  of a  10  m dilution of fully infective 
Rous virus, a dose that would be expected to produce tumors in 100 per cent of susceptible 
chickens. Tumors did not occur in the immunized birds. Serum was obtained 3 to 5 weeks 
after the challenge with infective virus, stored at --70°C., and later assayed for virus neutrali- 
zation titer. This undiluted antiserum in mixture with decimal dilutions of Rous virus produced 
a  loss of 6 logsls in the end-point dilutions of virus when assayed by the wing web or  the 
chorioallantoic membrane methods. 
Fluorescent  Antibedy.--The  crude  gamma  globulin  fraction  of  chicken  antiserum  was 
obtained by fractionation with cold ethanol at 25 per cent concentration (2) and was conju- 
gated with fluorescein isothiocyanate (12). The protein concentration in the reaction mixture 
was 20 rag. per ml., and fluorescein  isothiocyanate was used in the ratio of 0.05 mg. per nag. 
of protein. Prior to use, fluorescent antibody in 1 ml. quantity was absorbed with 150 rag. of 
rabbit bone marrow powder. This powder was prepared from red marrow homogenate by 
acetone precipitation and thorough washing with isotonic saline (buffered at pH 7.6 with 0.01 
phosphate). R. C. MELLORS  AND J. S. MUNROE  965 
While the present study was carried out with the direct procedure, using fluorescein-labeled 
chicken antibody against Rous sarcoma virus, the indirect procedure has also been successfully 
employed. Unlabeled chicken antiserum against Rous sarcoma virus comprised the first layer 
of protein,  and  fluorescein-labeled rabbit antibody against  chicken globulins was  the final 
reactant. 
Tissues and Frozen Sections.--Tissue specimens were obtained from 101 young chickens 
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Tv.xT-Fxo. 1. The concentration of extractable virus in wing tumors produced in chickens 
by various initiating doses (ordinate) of Rous virus. 
and connective tissue, 33; lung tumors,  2; chorioallantoic membrane tumors,  8; and other 
tissues (heart, lung, liver, spleen, 4 each), 16. Control tissues were derived from 18 uninoculated 
normal chickens and 1 chick embryo: wing muscle and connective tissue, 12; heart, 6; liver, 
5; spleen,  6; and chorioallautoic membrane,  1.  In addition, wing muscle, spleen,  and liver 
were received from 4 chickens which had been inoculated 27 to 41 days previously by Dr. 
Ben Burmester with his RPL 12 strain of virus that induces erythroblastosis and produces 
visceral lymphomatosis in about 80 per cent of chickens during the period of about  100 to 
t45 days after inoculation. 
Fresh tissue blocks were placed in stoppered  containers, frozen at  --70°C. in a  bath of 
dry ice and acetone, stored in a freezer at --25  ° to --30°C., sectioned in a microtome cryostat 
at an indicated thickness of 4/z, dried for 10 minutes at room temperature, and stored in the 966  ROUS  SARCOMA VIRUS 
refrigerator in sealed containers. From the total of 158 tissue blocks which were accessioned 
during this study, 221 frozen sections were prepared and stained with fluorescent antibody. 
Immunofluorescence Staining Procedures.--As needed, frozen sections were removed from 
the refrigerator, fixed with anhydrous acetone for 15 minutes at room temperature, air-dried, 
washed four times with buffered saline solution (pH 7.6), drained, blotted, and treated with 
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PER CENT OF' SA'I~COMA CELLS WITH ~OU6 VIRAL ANTIGENS 
TEXT-FIG. 2.  The per cent  of sarcoma  cells with Rous viral antigens  demonstrated  in 
sections of wing tumors with fluorescent antibody and related to the tumor-initiating dose 
of virus (upper curve with left ordinate)  and the concentration of extractable virus  (lower 
curve with right ordinate). 
the appropriately  absorbed  fluorescent  antibody  or  other reactant.  Staining and  blocking 
reactions were carried out for 60 minutes at room temperature. 
The immunospecific staining patterns of Rous viral antigens discussed  in this paper were 
obtained with fluorescein-labeled  chicken antibody against Rous sarcoma virus. Absorption 
of this fluor with acetone-precipitated, saline-insoluble rabbit bone marrow  powder  reduced 
non-specific staining to imperceptible or negligible levels•  Prior treatment  of sections with 
unlabeled chicken antiserum against Rous sarcoma virus (but not chicken serum lacking such 
antibodies) prevented the staining of viral antigen with fluorescent antibody. Prior treatment 
of sections with unlabeled chicken antiserum, obtained from Dr. Ben Burmester and shown 
by him to neutralize avian leukosis virus (erythroblastosis and lymphotosis) and Rous sarcoma 
virus, substantially decreased the staining of Rous viral antigen with fluorescent antibody. R.  C. MELLORS  AND  J.  $. MUN'ROE  967 
Conjugates prepared from heterologous antiserums did not stain the tissues of interest, nor 
did fluorescent antibody for Rous viral antigens stain the normal tissues obtained from un- 
inoculated healthy young chickens (the serums of which lacked Rous virus neutralizing anti- 
bodies),  chickens with latent leukosis virus infection (obtained  from Dr.  Burmester),  and 
uninoculated chick embryos. 
Fluorescence M@roscopy and Photography.--These  procedures  have been described else- 
where (10).  The exciter filters were UG5 (for visual work), UG2  (color  photography),  and 
BG12 (black and white photography). The barrier filters were BG23 and GG4 (for visual and 
color work) and OG4 and OG5 (for black and white photography). 
The quantitative histological method of area sampling (5) with an eyepiece net micrometer 
was used to count the proportion of sarcoma cells containing Rous viral antigens. In randomly 
selected fields,  additively covering the entire section without overlap, the number of inter- 
section points falling on sarcoma cells containing apple-green loci of viral antigens was de- 
termined and divided by the total number of points falling on sarcoma cells of all kinds. This 
quotient multiplied by 100 gave the per cent of sarcoma cells containing Rous viral antigens. 
A total of 12,010 sarcoma cells in tissue sections from 17 wing tumors was evaluated in this 
manner. The tumors were produced by each of four dilutions (10  ~, 10  -4, 10  -~, and 10  -¢) of 
Rous sarcoma virus  (Table I). At each category of dilution, an average of 3,000  sarcoma 
cells in sections of 3 to 6 wing tumors were analyzed. Innumerable sarcoma cells lacking viral 
antigens were scanned in multiple sections of 2 wing tumors produced by a  10  -s dilution of 
VirUS. 
Other Histological Procedures.--In  almost all instances blocks of tissue were also fixed in 
neutral formalin, embedded in paraffin, cut at 4/~, and stained with Harris' hematoxylin and 
picric acid--eosin, hematoxylin-eosin and alclan blue, and phosphotungstic acid-hematoxylin. 
Frozen sections, including those treated with fluorescent antibody as well as companions to 
these, were stained with hematoxylin and eosin. 
RESULTS 
The following descriptions pertain to the immunospecific, apple-green staining 
patterns imparted by fluorescent antibody to Rous sarcoma viral antigens in 
frozen sections of wing tumors  (obtained under the experimental conditions 
summarized in Table I), wing muscle and connective tissue, and pulmonary 
tumors of young chickens and chorioallantoic membrane tumors of the chick 
embryo. 
Wing Tumors.--If the tumor-initiating dose of virus is sufficiently high, an 
abundance of sarcoma cells are seen in low power fields to contain Rous viral 
antigens, Fig. 1. In such fields some of the virus-containing sarcoma cells tend 
to  be  elongated and  to  stream out in  characteristic  growth patterns,  while 
others, more commonly plump than spindle-shaped, are distributed in random 
and loose array in tumor mucoid. At higher magnification, Figs. 2 to 11, varia- 
tions in the cellular site (cytoplasm, cell membrane, and nucleus), distribution 
(particulate or homogeneous), and quantity (little or much) of viral antigens 
are seen. The smallest focus of viral antigens consists of one or more tiny round 
particulates  which are  visualized down  to  the  limit of resolution of an oil- 
immersion ob'ective and located in the cytoplasm, Fig. 5, or near the nuclear 
membrane,  or  on  the  cell  membrane  (and  conceivably then  extracellular). 968  ROUS  SARCOMA  VIRUS 
The cytoplasmic foci of viral antigens may enlarge or coalesce to form coarse 
particulates,  Fig. 3,  aggregates, or packets,  Fig. 6.  Viral antigens below the 
limit of optical resolution had an indistinctly  particulate, Fig. 7, or homogeneous 
distribution over a limited region, Fig. 8, or an extended area of the cytoplasm, 
Fig. 9. Particulate and homogeneous distributions of viral antigens sometimes 
coexist in the same cell.  The maximum cellular content of viral antigens, as 
judged by the intensity and the area of cytoplasmic immunofluorescence, occurs 
in  large  sarcoma  cells,  notably those  having plump,  polyhedral,  or  bizarre 
shapes,  Figs. 6  to 9.  These cells  tend to occur alone or in small groups and 
contrast with smaller neighboring sarcoma cells which may lack demonstrable 
antigen. While Rous viral antigens are localized almost exclusively in the cyto- 
plasm, one, or rarely more than one, homogeneous round focus of immunospecific 
apple-green fluorescence of low intensity is occasionally present in the nucleus 
of sarcoma cells,  Figs, 10 and 11. A nucleolar-like, spherical body with faint 
blue-violet intrinsic fluorescence is sometimes observed at the oil-immersion 
focal planes immediately below. Trace or larger amounts of viral antigens may 
coexist in the  cytoplasm. 
The quantitative relations between the tumor-initiating dose of Rous sarcoma 
virus, the infectivity titer of virus extracted from the wing tumor, and the per 
cent of sarcoma cells containing Rous viral antigens are shown in Table I  and 
Text-fig. 2.  If the  tumor-initiating dose of virus is high  (200,000  and 2,000 
TD60 respectively provided by 10  -2 and 10-* dilutions of a  standard prepara- 
tion), approximately 10  to  12  per  cent of sarcoma cells  contain Rous viral 
antigens as demonstrated in frozen sections of wing tumors stained with fluores- 
cent antibody. If the initiating dose of virus is low (2 and 0.2 TD60 respectively 
provided  by  10-  7 and  10  -s  dilutions of the identical standard preparation), 
0 to 0.05 per cent of sarcoma cells contain viral antigens. Although the precise 
nature of the curve relating log tumor-initiating dose and per cent of sarcoma 
cells  containing viral  antigens is  not established  for intermediate points  in 
Text-fig. 2, the data obtained at high and low dilutions are statistically resolved, 
with a probability for chance occurrence of less than 0.01.  Similar statements 
can be made for data pertaining to the titer of virus extracted from the wing 
tumors expressed as log TDs0 per gm. of tumor and the per cent of antigen- 
containing sarcoma cells in sections of the wing tumors. In tumors yielding high 
concentrations of extractable virus (log TDs0 equals 8.2 and 6.9), a substantial 
proportion of sarcoma cells  (12  and  10 per  cent, respectively) contain viral 
antigens; and in  tumors  with low concentrations of virus  (log TDs0  equals 
2.9 and 2.8),  only a minute proportion of sarcoma cells  (0.05 and 0 per cent, 
respectively) contain viral antigens detectable with fluorescent antibody. The 
data obtained at high and low concentrations of extractable virus are statis- 
tically resolved,  with a  probability for chance occurrence of less  than 0.01. R.  C.  M.ELLORS  AND  J.  S. M~UNR0~.  969 
While the precise location of intermediate points is not established for the upper 
or the lower curves in Text-fig. 2 relating assays of virus in the tumor-initiating 
dose and in the tumor extract to the per cent of sarcoma cells containing viral 
antigens, it is to be noted that virus assay points do not deviate by more than 
1 log unit from the hypothetical pair of parallel lines constructed in this figure. 
Wing  Muscle and  Connective Tissue.--Microscopic  foci  of  sarcoma  cells 
containing Rous viral antigens were noted in sections of skeletal muscle and 
connective tissue in three of four wing specimens obtained from chickens at 4 
days after inoculation of the wings with a  10  -2 dilution of the standard, cell- 
free  (three times frozen and thawed) preparation of Rous sarcoma virus. In 
one typical focus, comprising in all about 50 polyhedral-shaped sarcoma cells, 
approximately a dozen cells contained viral antigens, Figs. 12 and 13, while in 
another, Figs. 14 and 15, in which sarcoma cells  had arisen along the needle 
track the majority (more than half) of the sarcoma cells in a microscopic field 
contained a  finely particulate or homogeneous distribution of viral antigens. 
In three of four specimens, viral antigens were also localized in the skeletal 
muscle of the inoculated wing, Figs. 16 and 17, in a  characteristic pattern of 
deposition near or on the sarcolemma. This immunospecific focal pattern of 
virus localization in muscle, which has also been observed on occasion in the 
muscle residues in fully established wing tumors, Fig. 19, is selective, affecting 
but a few of many muscle fibers, and is not obviously traceable by continuity 
to a neighboring focus of sarcoma cells. That is to say, foci of virus localization 
in muscle and in sarcoma cells occur independently in the same section and in 
one or two adjacent ones (the practical numerical limit of serial frozen sections). 
Moreover,  viral  antigens  were  focally localized  as  fine  particulates  on  the 
sarcolemma of a  few muscle fibers in two of four wings examined at 3  days 
after virus inoculation, Fig.  18,  although sarcoma cells  were not yet demon- 
strable in the tissue sections. Wing muscle and connective tissue obtained at 
2  hours,  24  hours,  and  2  days after virus inoculation did not contain viral 
antigens demonstrable with fluorescent antibody. Virus was not detectable in 
wing web by bioassay until 4 days after inoculation. 
Others.--Rous  viral  antigens  were  observed  in  some  sarcoma  cells  in  a 
pulmonary tumor, Fig. 20, coexisting with wing tumor in a chicken which had 
been inoculated with virus 15 days previously. The intracellular distribution of 
viral  antigens  was  qualitatively similar  to  that  described  for  wing  tumors. 
Viral antigens were not detected in the lungs of chickens at 24 hours and at 
4 days after virus inoculation in the wing, although bioassay revealed detectable 
virus in the lungs as early as 24 hours after wing-web inoculation. 
Viral antigens were present in sarcoma cells in the chorioallantoic membrane 
tumors of the chick embryo, inoculated at 11 days of age and harvested 6 days 
later, Fig. 21. 970  ROUS  SARCOMA  VIRUS 
DISCUSSION 
The dependence upon  initiating  dose  of the  amount  of virus  extractable 
from Rous sarcoma has been shown by the extensive work of Bryan, Calnan, 
and Moloney (1).  Epstein  (4)  observed a  statistically significant correlation 
between the incidence of Rous ascites tumor cells containing virus-like particles 
identified with  the electron microscope and  the  tumor-producing activity of 
virus extractable from the tumor cells.  Haguenau, Dalton,  and Moloney (6) 
demonstrated a  correlation between  the  particle  count in  ultrathin  sections 
of wing tumors and the concentration of infective virus recoverable from these 
tumors.  Particle counts and  content of extractable virus were much greater 
in the category of tumors produced by a high, as contrasted with a low, initiating 
dose of Rous virus. These combined morphological and biological studies have 
shown therefore that  the virus-like particles represent, or are  quantitatively 
related to, the causative agent of Rous sarcoma. 
With  the  exception of limited  comments  and  illustrations  presented else- 
where (8,  9,  11 a) and representing observations that for the most part were 
preliminary to the present investigation, there is but one other publication to 
date which deals with the fluorescent-antibody detection of Rous sarcoma virus. 
Malmgren,  Fink,  and  Mills  (7)  illustrated  the  particulate  and  the  diffuse 
distribution of viral antigens in the cytoplasm of sarcoma cells and also  the 
presence of a poorly defined mass of viral antigens in the nucleus. They found 
that viral antigen-containing cells were very numerous in Rous sarcomas pro- 
duced by large amounts of virus and were much less frequent in tumors in- 
duced with  a  low concentration of virus.  Numerical  counts for antigen  foci 
were not given in their work, and the content of extractable virus in the tumors 
was not determined. 
The present studies, in showing the quantitative proportional relations be- 
tween the initiating dose, the recoverability, and the morphological detectability 
(as antigens)  of Rous  sarcoma virus in wing tumors, are  in agreement with 
those previously cited. In addition, by reference to Table I  and Text-fig. 2 it 
is seen that the least amount of Rous viral antigens detectable by fluorescent 
antibody in tissue sections is found in wing tumors with  virus  concentrations 
of about  103 TD60 per gm.  Assuming  that  1 gin.  of tumor occupies about  1 
cm  3. (101~/P),  a virus concentration of 103 TD~0 per gm. becomes 1 TDs0 per 
109 #~. A tissue section with an area of 1 cm3 (10  s #2) and a thickness of 10 # 
has a volume of 109 #3, corresponding to a virus content of 1 TDs0. Therefore 
if localized in sufficient concentration, 1 TD~0 of virus would apparently cor- 
respond to one immunofluorescent focus per tissue section, which was in fact 
the approximate number observed in sections of tumors of low virus concentra- 
tion (log TDs0 equals 2.9 per gin.). Assuming that one infectious (tumor-pro- 
ducing)  unit  of  Rous  virus  comprises  50  spherical  virus  particles  (4),  with 
diameters of 70 m#, the diameter of a  sphere having a volume of 50 particles R.  C.  MELLORS  AND  J.  $.  MIINROE  971 
equals 0.26/z and the diameter of the sphere which encloses all of the particles 
is larger than that. Thus if a  spherical aggregate of 50 virus particles corre- 
sponds  to  one  tumor-producing unit  of  Rous  virus,  it  would  be  optically 
resolved and, if sufficient in antigen content, would be detected as an immuno- 
fluorescent focus in  a  microscope.  A  solitary particulate  focus of immuno- 
fluorescence with size near the limit of resolution of an oil-immersion objective 
is  the  smallect  amount  of  Rous  viral  antigens  detectable  in  an  individual 
sarcoma cell. If representing infective virus, such an immunofluorescent focus 
apparently would correspond to one tumor-producing unit. However, one must 
acknowledge the possibility that the nucleic acid moiety of Rous virus may be 
by itself infective. 
In several respects, the present work is in accord with the observations of 
Rubin (13). This investigator plated a known number of intact Rous sarcoma 
cells on the chorioallantoic membrane. Each tumor formed was found to arise 
from one virus-releasing cell,  that  is,  each implanted cell could account for 
no more than one tumor. Moreover, an average of about one cell in eight (12.5 
per  cent)  yielded a  tumor on the  chorioallantoic membrane.  In  the present 
study,  when  the  initiating  doses  of virus corresponded to dilutions of 10  -* 
and  10  -4,  10  to  12  per  cent of sarcoma  cells contained Rous viral  antigens 
demonstrable with fluorescent antibody. Rubin also found that enlarged cells 
practically always  produced  tumors  and  that  some  of  these  cells  produced 
sufficient virus to infect the chorioallantoic membrane at 20 or 30 places. In 
the present investigation, large  sarcoma cells,  Fig.  9,  contained the greatest 
quantity of Rous viral antigens per cell as estimated from the product or in- 
tegral  of  immunofluorescence intensity  and  cytoplasmic  area. 
The most unexpected finding in  the present study was  the localization of 
Rous viral antigens on the sarcolemma of wing muscle, which at first thought 
was presumed to be a  consequence of local diffusion of viral antigens from a 
neighboring focus of sarcoma cells in the interstitial fibrous tissue. That this 
explanation alone was not sufficient was suggested, however, by the observa- 
tion that viral antigens were localized on the sarcolemma at 3 days after virus 
inoculation, at a  time when sarcoma cells were not identifiable in the  tissue 
sections.  Nevertheless,  a  careful  histological  study  of  the  muscle  fibers  in 
paraffin sections disclosed no cytopathic effects attributable to Rous virus. While 
this problem requires further investigation, it is of interest in respect to the 
recent studies of Ebert (3). In his experiments, chicken heart tissue and Rous 
sarcoma tissue were mixed and extracted together, and a  cell-free preparation 
of Rous virus was made from the extract. When  this conjoined extract was 
inoculated into the chorioallantoic membrane of the chick, it caused the forma- 
tion of tumors containing striated muscle fibrils. Presumably some association 
between virus particles and muscle-cell constituents had occurred during extrac- 
tion, and a  transduction-like reaction had ensued. 972  ROUS  SARCOMA  VIRUS 
SUMMARY  AND CONCLUSIONS 
A study has been made of the immunospecific, apple-green staining  patterns 
imparted by fluorescent  antibody to Rous virus in frozen  sections  of wing 
tumors produced in young chickens by various initiating  doses of virus.  Varia- 
tions  in the cellular  site  (cytoplasm, cell  membrane, and nucleus),  the distribu- 
tion (particulate  or homogeneous), and the quantity (little  or much) of Rous 
viral antigens were seen. The per cent of sarcoma cells containing viral antigens 
was related to the tumor initiating dose of virus and to the infectivity titer of 
virus extracted from the wing tumor. With certain assumptions it was estimated 
that a  quantity of virus approaching one tumor-producing dose (1  TDs0) per 
tissue section was detectable with fluorescent antibody. 
Sarcoma cells  containing  viral antigens  were  identified  as early as 4  days 
after inoculation of Rous virus. At this time viral antigens were also localized 
in the skeletal muscle of the inoculated wing in a characteristic focal pattern of 
deposition near or on the sarcolemma. This association between viral antigens 
and skeletal muscle fibers was observed also at 3 days after virus inoculation, 
when sarcoma cells were not yet demonstrable in the tissue sections. 
Viral antigens were detected in sarcoma cells in lung tumors of young chickens 
and in tumors of the chorioallantoic membrane of chick embryos. 
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EXPLANATION OF PLATES 
PLATE 81 
The illustrations  are fluorescence  photomicrographs of 4 #  thick, frozen sections 
of chicken tissues  stained  with  the  direct fluorescent  antibody procedure.  The  de- 
scriptions pertain  to the immunospecific staining of Rous viral antigens. 
FIG.  1.  Rous  sarcoma,  wing  tumor  with  log  TD~0/gm.  equals  7.8.  Rous  viral 
antigens (white areas) in the cytoplasm of many sarcoma cells.  ×  100. 
F~G.  2.  Wing  tumor.  Rous  viral  antigens  with  particulate  and  non-particulate 
(homogeneous) distributions in a focus of sarcoma cells.  X  1500. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 112  PLATE  81 
(Mellors  and  Munroe:  Rous  sarcoma  virus PLATE 82 
FIe;.  ,;i. Wing  tumor.  Rous sarcoma cell with  fine and  coarse particulate  distribu- 
tion  of  viral  antigens  in  cytoplasm.  X  1500. 
Fro.  4.  Wing  tumor.  Rous  sarcoma  cell  with  coarse  particulate  distribution  of 
viral antigens  in  cytoplasm  near  nuclear  membrane.  X  1500. 
Fro.  5.  Wing  tumor.  Rous  sarcoma  cell  with  fine  paNiculalc  and  indislinctlv 
granular  distribution  of  viral antigens  in  cytoplasm.  X  tS00. 
Fro.  6.  Wing  tumor.  Rous  sarcoma  cell  with  small  and  large  aggregates  of  viral 
antigens  in  cytoplasm.  X  1500. 
Fro.  7.  Wing tumor.  Rous sarcoma cell wilh indistinctly particulate viral antigens 
occupying the major area of the cytoplasm.  X  1500. 
Fro.  8.  Wing  tumor.  Rous  sarcoma  cell  with  homogene,ms  distribution  of  viral 
antigens in portion of cytoplasm.  X  1500. 
Fro. 9.  Wing tumor. Large  Rous  sarcoma  cell with  abundance  of  viral  antigens 
in cytoplasm.  X  1500. 
F~(;.  lO.  Wing  lumor.  Rous  sarcoma  cell  with  viral  antigens  in  eccentric  oval 
focus in the nucleus and also in the cytoplasm.  X  1000. 
Fro.  11.  Wing  tumor.  Rous sarcoma cell with  viral antigcns  in  nucleus and  cyto- 
plasm.  ×  1500. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  112  PLATE  82 
(Mellors  and  Munroe:  Rous  sarcoma  virus) PLATE  83 
FiG.  12.  Wing muscle at. 4 days after virus inoculation.  Microscopic focus of Rous 
sarcoma  cells containing  viral  antigens.  X  560. 
FiG.  13,  Same  field  as  Fig.  12  photographed  in  phase  contrast.  X  560. 
Fro.  14.  Wing  muscle  at  4  days  after  virus  inoculation.  In  a  needle  track, 
a  microscopic focus of Rous sarcoma  cells containing viral antigens.  X  200. 
Fie,.  15.  Same  field  as  Fig.  14  photographed  in  phase  contrasl.  X  21~0. 
FIG. 16. Wing muscle at 4 days after virus inoculation. Rous viral antigens localized 
on  or  near  the sarcolemma  of  a  few of  the  muscle  fibers.  X  560. 
Fro.  17.  Same  field  as  Fig.  16  photographed  in  phase  contrast.  X  56(I. TIIE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  112  PLATE  83 
(Mellors  and  Munroe:  Rous  sarcoma  virus) PLATE 84 
FIG.  lg.  Wing  muscle  at  3  clays  after  virus  inoculation.  Rous  viral  antigens 
localized as fine particulates  on the sarcolemma o[ one muscle fiber.  X  1500. 
Fro.  19.  Muscle in fully established  wing tumor.  No identifiable sarcoma cells are 
present in this field. Rous viral antigens localized on the sarcolemrna of a  few muscle 
fibers.  X  1500. 
FiG. 20.  Lung tumor.  Rous viral antigens localized in sarcoma cells.  ×  200. 
FiG.  21.  Chorioallantoic membrane  tumor.  Rous viral antigens  localized  in  cyto- 
plasm  of  sarcoma  cells.  X  200. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  112  PLATE  84 
(MeUors  and  Munroe:  Rous  sarcoma  virus) 